Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

PURPOSE: The optimal regimen intensity before allogeneic hematopoietic cell transplantation (HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with reduced-intensity conditioning (RIC) would result in improved overall survival (OS) compared with myeloablative conditioning...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Principais autores: Scott, Bart L., Pasquini, Marcelo C., Logan, Brent R., Wu, Juan, Devine, Steven M., Porter, David L., Maziarz, Richard T., Warlick, Erica D., Fernandez, Hugo F., Alyea, Edwin P., Hamadani, Mehdi, Bashey, Asad, Giralt, Sergio, Geller, Nancy L., Leifer, Eric, Le-Rademacher, Jennifer, Mendizabal, Adam M., Horowitz, Mary M., Deeg, H. Joachim, Horwitz, Mitchell E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455603/
https://ncbi.nlm.nih.gov/pubmed/28380315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.7091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados